130 related articles for article (PubMed ID: 36755388)
1. Vitamin D supplementation for children with mild to moderate asthma: an economic evaluation.
Antonio Buendía J; Patiño DG; Lindarte EF
J Asthma; 2023 Sep; 60(9):1668-1676. PubMed ID: 36755388
[TBL] [Abstract][Full Text] [Related]
2. Cost utility of vitamin D supplementation in adults with mild to moderate asthma.
Antonio Buendía J; Rodriguez-Martinez CE; Sossa-Briceño MP
J Asthma; 2023 May; 60(5):951-959. PubMed ID: 35920247
[TBL] [Abstract][Full Text] [Related]
3. Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma.
Buendía JA; Patiño DG
BMC Pulm Med; 2021 Dec; 21(1):398. PubMed ID: 34865635
[TBL] [Abstract][Full Text] [Related]
4. Cost-utility of azithromycin in patients with severe asthma.
Buendía JA; Patiño DG; Feliciano-Alfonso JE
J Asthma; 2022 Oct; 59(10):2008-2015. PubMed ID: 34516322
[TBL] [Abstract][Full Text] [Related]
5. Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma.
Buendía JA; Patiño DG
BMC Pulm Med; 2021 Dec; 21(1):397. PubMed ID: 34865628
[TBL] [Abstract][Full Text] [Related]
6. Tiotropium for children and adolescents with severe asthma.
Antonio Buendía J; Patiño DG
J Asthma; 2023 May; 60(5):1009-1015. PubMed ID: 36047659
[TBL] [Abstract][Full Text] [Related]
7. Cost-utility analysis of the inhaled steroids available in a developing country for the management of pediatric patients with persistent asthma.
Rodríguez-Martínez CE; Sossa-Briceño MP; Castro-Rodriguez JA
J Asthma; 2013 May; 50(4):410-8. PubMed ID: 23356720
[TBL] [Abstract][Full Text] [Related]
8. Cost-utility analysis of prenatal supplementation with long-chain n-3 fatty acids to reduce the incidence of wheezing and asthma in neonates.
Buendia JA; Guerrero-Patino D; Zuluaga A
J Asthma; 2024 Mar; ():1-9. PubMed ID: 38427828
[TBL] [Abstract][Full Text] [Related]
9. Cost-utility analysis of dupilumab add on therapy versus standard therapy in adolescents and adults for severe asthma in Colombia.
Antonio Buendía J; Patiño DG
Expert Rev Pharmacoecon Outcomes Res; 2022 Jun; 22(4):575-580. PubMed ID: 34860616
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children.
Buendía JA; Patiño DG
Cost Eff Resour Alloc; 2023 Apr; 21(1):23. PubMed ID: 37024913
[TBL] [Abstract][Full Text] [Related]
11. SMART therapy in adolescent and adults patients with moderate persistent asthma: a cost-utility analysis.
Buendía JA; Patiño DG
J Asthma; 2022 Dec; 59(12):2367-2374. PubMed ID: 34913809
[TBL] [Abstract][Full Text] [Related]
12. Cost‑effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma.
Buendia JA; Guerrero Patiño D; Cossio-Giraldo YE
J Asthma; 2022 Oct; 59(10):2016-2023. PubMed ID: 34551659
[TBL] [Abstract][Full Text] [Related]
13. Cost Utility of Intermittent Inhaled Corticosteroids in Preschoolers with Viral-Triggered Wheeze.
Buendía JA; Guerrero Patiño D; Giraldo Ramírez JE
Pediatr Allergy Immunol Pulmonol; 2022 Mar; 35(1):36-42. PubMed ID: 35320007
[No Abstract] [Full Text] [Related]
14. Cost-utility of tiotropium in patients with severe asthma.
Buendía JA; Patiño DG
Cost Eff Resour Alloc; 2024 Jan; 22(1):4. PubMed ID: 38238836
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma.
Zafari Z; Sadatsafavi M; Marra CA; Chen W; FitzGerald JM
PLoS One; 2016; 11(1):e0146003. PubMed ID: 26751790
[TBL] [Abstract][Full Text] [Related]
16. Vitamin A supplementation for the prevention of chronic lung disease in premature infants: A cost-utility analysis.
Buendía JA; Guerrero Patiño D; Lindarte EF
Pediatr Pulmonol; 2022 Oct; 57(10):2511-2517. PubMed ID: 35794801
[TBL] [Abstract][Full Text] [Related]
17. Fluticasone furoate plus vilanterol in patients with moderate persistent asthma: a cost-utility analysis.
Antonio Buendía J; Patiño DG
J Asthma; 2023 Feb; 60(2):377-384. PubMed ID: 35261332
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of linezolid to ventilator-associated pneumonia in Colombia.
Buendía JA; Patiño DG; Zuluaga Salazar AF
BMC Infect Dis; 2024 Jan; 24(1):98. PubMed ID: 38238670
[TBL] [Abstract][Full Text] [Related]
19. Cost-utility analysis of reslizumab for patients with severe eosinophilic asthma inadequately controlled with high-dose inhaled corticosteroids and long-acting β
Han S; Kim S; Kim H; Suh HS
Curr Med Res Opin; 2019 Sep; 35(9):1597-1605. PubMed ID: 30964365
[No Abstract] [Full Text] [Related]
20. Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.
Wilson EC; Price D; Musgrave SD; Sims EJ; Shepstone L; Murdoch J; Mugford HM; Blyth A; Juniper EF; Ayres JG; Wolfe S; Freeman D; Gilbert RF; Hillyer EV; Harvey I
Pharmacoeconomics; 2010; 28(7):597-608. PubMed ID: 20446755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
